These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7188034)

  • 1. The short- and long-term effects of haloperidol on rat central dopamine turnover.
    Tsutsumi T; Kojima H; Anraku S; Inanaga K
    Brain Res; 1982 Jan; 232(2):485-8. PubMed ID: 7188034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the effects of haloperidol on dopamine turnover in the striatum, olfactory tubercule and median eminence.
    Gudelsky GA; Moore KE
    J Pharmacol Exp Ther; 1977 Jul; 202(1):149-56. PubMed ID: 874811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic treatment with SCH 23390 and haloperidol: effects on dopaminergic and serotonergic mechanisms in rat brain.
    Lappalainen J; Hietala J; Koulu M; Seppälä T; Sjöholm B; Syvälahti E
    J Pharmacol Exp Ther; 1990 Feb; 252(2):845-52. PubMed ID: 2179533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine receptors and ergot drugs. Evidence that an ergolene derivative is a differential agonist at subcortical limbic dopamine receptors.
    Fuxe K; Fredholm BB; Agnati LF; Corrodi H
    Brain Res; 1978 May; 146(2):295-311. PubMed ID: 647392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic clozapine versus chronic haloperidol treatment: differential effects on electrically evoked dopamine efflux in the rat caudate putamen, but not in the nucleus accumbens.
    Feasey-Truger KJ; Alzheimer C; ten Bruggencate G
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Dec; 354(6):725-30. PubMed ID: 8971732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of regional brain dopamine systems to haloperidol.
    Kolenik SA; Hoffman FJ; Bowers MB
    Biol Psychiatry; 1989 Mar; 25(6):815-7. PubMed ID: 2923943
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential drug effects on dopamine concentrations and rates of turnover in the median eminence, olfactory tubercle and corpus striatum.
    Gudelsky GA; Moore EK
    J Neural Transm; 1976; 38(2):95-105. PubMed ID: 1271052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in striatal dopamine D2 receptor mRNA after lesions of haloperidol treatment.
    Coirini H; Schumacher M; Angulo JA; McEwen BS
    Eur J Pharmacol; 1990 Sep; 186(2-3):369-71. PubMed ID: 2127022
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action of haloperidol on the ultrastructure of areas of the dopaminergic system of the brain].
    Klintsova AIu; Uranova NA; Schenk H; Hasselhorst U
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(7):1028-31. PubMed ID: 3673382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in evoked dopamine efflux in rat caudate putamen, nucleus accumbens and tuberculum olfactorium in the absence of uptake inhibition: influence of autoreceptors.
    Trout SJ; Kruk ZL
    Br J Pharmacol; 1992 Jun; 106(2):452-8. PubMed ID: 1393270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ergot alkaloids: interaction with presynaptic dopamine receptors in the neostriatum and olfactory tubercles.
    Marek KL; Roth RH
    Eur J Pharmacol; 1980 Mar; 62(2-3):137-46. PubMed ID: 6769681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain.
    O'Dell SJ; La Hoste GJ; Widmark CB; Shapiro RM; Potkin SG; Marshall JF
    Synapse; 1990; 6(2):146-53. PubMed ID: 2237777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects.
    Han M; Huang XF; Deng C
    Int J Neuropsychopharmacol; 2009 Aug; 12(7):941-52. PubMed ID: 19203411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of haloperidol and low dose clozapine on the acetylcholine turnover rate in rat forebrain structures.
    Bluth R; Langnickel R
    Biomed Biochim Acta; 1985; 44(10):1531-9. PubMed ID: 4084256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic treatment with 1-sulpiride and haloperidol on central dopamine turnover evaluated in dopamine cell body and nerve terminal-rich areas.
    Agnati LF; Andersson K; Fuxe K; Benfenati F; Cortelli P; D'Alessandro R; Ogren SO
    Adv Biochem Psychopharmacol; 1980; 24():75-80. PubMed ID: 7405679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent lack of a dopaminergic-cholinergic link in the rat nucleus accumbens septi-tuberculum olfactorium.
    Consolo S; Ladinsky H; Bianchi S; Ghezzi D
    Brain Res; 1977 Oct; 135(2):255-63. PubMed ID: 922475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic haloperidol during development attenuates dopamine autoreceptor function in striatal and mesolimbic brain regions of young and older adult rats.
    Scalzo FM; Spear LP
    Psychopharmacology (Berl); 1985; 85(3):271-6. PubMed ID: 3923514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic prenatal haloperidol exposure: lack of effect on presynaptic dopamine autoreceptors.
    Scalzo FM; Newport GD; Gough BJ; Ali SF; Holson RR
    Neurotoxicology; 1989; 10(3):485-90. PubMed ID: 2516618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D1 receptors function to inhibit the activation of tuberoinfundibular dopamine neurons.
    Berry SA; Gudelsky GA
    J Pharmacol Exp Ther; 1990 Aug; 254(2):677-82. PubMed ID: 1974647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic regulation of dopamine and serotonin responses to salient stimuli during chronic haloperidol treatment.
    Amato D; Natesan S; Yavich L; Kapur S; Müller CP
    Int J Neuropsychopharmacol; 2011 Nov; 14(10):1327-39. PubMed ID: 21281560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.